These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV. Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [Abstract] [Full Text] [Related]
6. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Kaufman DW, Kelly JP, Anderson T, Harmon DC, Shapiro S. Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520 [Abstract] [Full Text] [Related]
8. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Avanzini G, Canger R, Dalla Bernardina B, Vigevano F. Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923 [Abstract] [Full Text] [Related]
10. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame? Thakkar K, Billa G, Rane J, Chudasama H, Goswami S, Shah R. Expert Rev Neurother; 2015 Mar; 15(12):1373-5. PubMed ID: 26566191 [Abstract] [Full Text] [Related]
11. Felbamate in epilepsy therapy: evaluating the risks. Pellock JM. Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399 [Abstract] [Full Text] [Related]
12. Some common issues in the use of antiepileptic drugs. Asconapé JJ. Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391 [Abstract] [Full Text] [Related]
14. [Felbamate: a long-term study in subjects with refractory epilepsy]. De Romanis F, Sopranzi N. Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844 [Abstract] [Full Text] [Related]
15. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Palmer KJ, McTavish D. Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493 [Abstract] [Full Text] [Related]
16. Taming the brain storms: felbamate updated. Brodie MJ, Pellock JM. Lancet; 1995 Oct 07; 346(8980):918-9. PubMed ID: 7564721 [No Abstract] [Full Text] [Related]
17. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D. Epilepsia; 1993 Oct 07; 34 Suppl 7():S30-3. PubMed ID: 8243376 [Abstract] [Full Text] [Related]
18. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J, Aguirre J, Parrilla JL, Pérez Miranda M. Rev Neurol; 1995 Oct 07; 23(124):1220-5. PubMed ID: 8556622 [Abstract] [Full Text] [Related]
19. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Brown WM, Aiken SP. Crit Rev Neurobiol; 1998 Oct 07; 12(3):205-22. PubMed ID: 9847055 [Abstract] [Full Text] [Related]
20. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Zupanc ML, Roell Werner R, Schwabe MS, O'Connor SE, Marcuccilli CJ, Hecox KE, Chico MS, Eggener KA. Pediatr Neurol; 2010 Jun 07; 42(6):396-403. PubMed ID: 20472190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]